ATE10340T1 - Stabilisierung der aktivitaet des faktors viii im blutplasma. - Google Patents

Stabilisierung der aktivitaet des faktors viii im blutplasma.

Info

Publication number
ATE10340T1
ATE10340T1 AT81305611T AT81305611T ATE10340T1 AT E10340 T1 ATE10340 T1 AT E10340T1 AT 81305611 T AT81305611 T AT 81305611T AT 81305611 T AT81305611 T AT 81305611T AT E10340 T1 ATE10340 T1 AT E10340T1
Authority
AT
Austria
Prior art keywords
calcium
factor viii
blood plasma
viii activity
heparin
Prior art date
Application number
AT81305611T
Other languages
English (en)
Inventor
Gail Ann Rock
Original Assignee
Gail Ann Rock
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gail Ann Rock filed Critical Gail Ann Rock
Application granted granted Critical
Publication of ATE10340T1 publication Critical patent/ATE10340T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/04—Heat
    • A61L2103/05—
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT81305611T 1980-11-26 1981-11-26 Stabilisierung der aktivitaet des faktors viii im blutplasma. ATE10340T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/210,383 US4359463A (en) 1980-11-26 1980-11-26 Stabilization of Factor VIII activity in whole blood or blood plasma
EP81305611A EP0053046B1 (de) 1980-11-26 1981-11-26 Stabilisierung der Aktivität des Faktors VIII im Blutplasma

Publications (1)

Publication Number Publication Date
ATE10340T1 true ATE10340T1 (de) 1984-12-15

Family

ID=22782688

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81305611T ATE10340T1 (de) 1980-11-26 1981-11-26 Stabilisierung der aktivitaet des faktors viii im blutplasma.

Country Status (6)

Country Link
US (1) US4359463A (de)
EP (1) EP0053046B1 (de)
JP (1) JPS5932442B2 (de)
AT (1) ATE10340T1 (de)
CA (1) CA1176163A (de)
DE (1) DE3167338D1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
DE3237512A1 (de) * 1982-10-09 1984-04-12 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von antihaemophilem kryopraezipitat (ahk) und danach hergestelltes antihaemophiles kryopraezipitat
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4871677A (en) * 1985-02-25 1989-10-03 Hemotec, Inc. Method of collecting and analyzing a sample of blood when monitoring heparin therapy
US4782026A (en) * 1985-02-25 1988-11-01 Hemotec, Inc. Collection medium for whole blood
GB8708181D0 (en) * 1987-04-06 1987-05-13 Wensley R Extraction of protein from blood
EP0357724B1 (de) * 1988-02-18 1992-12-02 Baxter International Inc. Stabilisierte heparinlösung
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
DE3938907C2 (de) * 1989-11-24 1999-11-04 Dade Behring Marburg Gmbh Mittel zum Lagern und Suspendieren von Zellen, insbesondere Erythrozyten
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
JPH04507108A (ja) * 1990-05-07 1992-12-10 バクスター、インターナショナル、インコーポレイテッド 安定化されたヘパリン溶液
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
DE4230513C1 (de) * 1992-09-11 1994-03-31 Fresenius Ag Vorrichtung zur Entfernung von Aluminiumionen aus Blut und Lösung zur Verwendung in der Vorrichtung
SE9302006D0 (sv) * 1992-10-02 1993-06-11 Kabi Pharmacia Ab Protein formulation
JP2000509374A (ja) 1996-04-19 2000-07-25 アルファ セラピュティック コーポレイション 凍結乾燥した血液タンパク質のウイルス不活性化方法
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US20020146409A1 (en) * 2001-01-30 2002-10-10 Herring Steven W. Methods for stabilizing lyophilized blood proteins
JP2006516630A (ja) * 2003-01-27 2006-07-06 ハーベスト テクノロジーズ インコーポレーテッド 抗凝固処理全血から産生される自己又は同種の凝固剤
ES2229931B1 (es) * 2003-10-03 2006-01-16 Grifols, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.
CA2567137A1 (en) * 2004-05-17 2005-12-08 Medtronic, Inc. Point of care heparin determination system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma

Also Published As

Publication number Publication date
EP0053046A1 (de) 1982-06-02
DE3167338D1 (en) 1985-01-03
JPS5932442B2 (ja) 1984-08-09
EP0053046B1 (de) 1984-11-21
CA1176163A (en) 1984-10-16
JPS5795916A (en) 1982-06-15
US4359463A (en) 1982-11-16

Similar Documents

Publication Publication Date Title
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
DE3587266D1 (de) Verfahren und system zur entfernung von immunosuppressiven bestandteilen aus saeugetierblut.
SG17493G (en) Ozone decontamination of blood and blood products
NZ210275A (en) Modified hirudin and its antithrombin properties
ATE27916T1 (de) Behandlung von knochenmarkentzuendungen.
IT8424080A0 (it) Procedimento perfezionato per il trattamento di tabacco.
ATE64530T1 (de) Verwendung von hyperimmunmilch zur herstellung eines arzneimittels zur behandlung von cardiovaskul|ren krankheiten und zur verringung von blutfettwerten.
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
EP0244834A3 (en) Process for producing a factor v concentrate
ES2070116T3 (es) Peptidos que inhiben la union del factor von willebrand.
ES8506450A1 (es) Procedimiento para higienizar o pasterizar fribrinogeno humano
NO872675D0 (no) Middel for hemning av avstoetning av transplanterte organer
SE8104482L (sv) Forfarande for framstellning av ett faktor viii (ahf)-hogkoncentrat
SE8009157L (sv) Sett att framstellning hogrenade koncentrat av protrombinkomplex, de erhallna koncentraten och framstellning derav
ATE78397T1 (de) Verwendung von p-chlorophenoxyazetat von n,ndimethylbiguanidzur behandlung von neuropathien und nervendegeneration.
JPS57122085A (en) Circulatory disease extirpenter and use
ES8604623A1 (es) Un procedimiento para la produccion de un complejo covalentemente enlazado de heparina-antitrombina-iii
EP0058397A3 (de) Antikoagulans und seine Verwendung
NO832092L (no) Fremgangsmaate ved fremstilling av et heparinfragment
IT8125819A0 (it) Agente promotore per la coagulazione del sangue.
IT8420442A0 (it) Trattamento del tabacco. procedimento migliorato per il
JPS5756426A (en) Novel salt and manufacture
IT8424079A0 (it) Procedimento perfezionato per il trattamento di tabacco.
BG28425A3 (en) Method of obtaining of heparin
IT8468265A1 (it) Derivati del 3-fenil-4H-1-benzopirano-4-one per la prevenzione o il trattamento dell'osteoporosi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee